CBD Life Sciences, Inc. (CBDL)
Reaches Unprecedented Heights With Explosive Growth and Strategic
Expansion in 2024
"Record-breaking revenue, new market
entries, and transformative partnerships highlight our path to
increasing shareholder value and long-term growth."
October 8, 2024 -- InvestorsHub NewsWire -- Dear Shareholders, 2024
has been a banner year for CBD Life Sciences, Inc. (CBDL),
and we are thrilled to provide you with an exciting corporate
update that underscores the massive growth and strategic
advancements that are rapidly transforming our business. As of
February 2024, we have achieved an extraordinary 1,405.46% increase
in revenue, our highest to date, cementing CBDL as a dominant
player in the booming CBD and wellness sectors.
This remarkable growth was driven by our aggressive expansion into
new retail markets. By entering Amazon and Walmart Marketplace, two
of the largest retail platforms globally, we have unlocked access
to over $950 billion in combined annual consumer spending. This
strategic move has resulted in a 300% growth in online sales since
launch, and we're just getting started.
Our product line continues to drive exceptional demand. The launch
of our Mellow Mornings nano CBD coffee creamers, along with our
fast-acting pain relief cream, has resonated deeply with consumers
looking for innovative, effective solutions. In fact, early sales
data shows a 500% increase in unit sales for our nano CBD products
alone, and our partnerships with local coffee shops have expanded
our reach exponentially, with CBD-infused beverages seeing an
average 40% increase in customer orders.
Our entrance into the cannabis market, through partnerships with
key dispensaries, is expected to fuel additional revenue growth in
2025, with the cannabis industry projected to reach $73.6 billion
by 2027. Our pipeline is filled with potential, and we anticipate
these moves will unlock multi-million-dollar opportunities for CBDL
in the coming quarters.
We are not just scaling, but we are scaling smartly, with a 40%
increase in gross margins year-over-year, thanks to our focus on
high-margin products and streamlined operations. Furthermore, we
are on track to deliver continued triple-digit growth, with
projected revenues for 2024 set to surpass $10 million, driven by
product innovation and continued retail expansion.
For shareholders, this means an extraordinary opportunity to
capitalize on one of the fastest-growing companies in the CBD
space. The company has no intentions of doing reverse split. Our
relentless focus on innovation, strategic market entry, and
partnerships with leading retailers positions us to not only meet
but exceed your expectations in the near future.
Thank you for your continued confidence and trust as we chart a
course to even greater heights.
Sincerely,
Lisa Nelson
President & CEO, CBD Life Sciences, Inc.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC
PINK: CBDL) is a forward-thinking, rapidly growing company
specializing in the development of innovative, high-quality CBD
products designed to enhance health and wellness. From pain relief
to stress reduction, CBDL is at the forefront of the CBD
revolution, consistently delivering premium products that meet the
evolving needs of consumers. With a commitment to cutting-edge
science and consumer satisfaction, CBDL is driving growth in the
fast-expanding CBD market.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters
discussed in this press release are forward-looking statements.
Actual results may differ materially from those described in
forward-looking statements and are subject to risks and
uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with
OTC Markets, which may identify specific factors that may cause
actual results or events to differ materially from those described
in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based
on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking ability to secure and maintain strategic
relationships and distribution agreements. The Company disclaims
any intention or obligation to update or revise any forward-looking
statements.
